Navigation Links
Stevens assists enXco with construction of solar photovoltaic system
Date:8/5/2008

HOBOKEN, N.J. On July 29, 2008, enXco, an EDF Energies Nouvelles company, announced that a Power Purchase Agreement (PPA) was made with Stevens Institute of Technology to construct a 487 kW solar photovoltaic system in Hoboken, N.J. The solar photovoltaic project will consist of roof-, carport- and ground-mounted fixed-tilt solar arrays. enXco will own and operate the solar photovoltaic system, and provide financing for the project under a multi-year PPA with Stevens on a net-metering basis.

Construction on the project is anticipated to begin mid-August 2008 and is expected to be in operation by the end of the year. EnXco has also signed an EPC agreement with RGD Energies, a subsidiary of 3rd Rock Systems and Technologies.


'/>"/>

Contact: Maria Molina
mmolina@stevens.edu
201-216-5602
Stevens Institute of Technology
Source:Eurekalert

Page: 1

Related biology news :

1. Stevens Center for Science Writings honors environmental critics with Green Book Award, April 30
2. Stevens researchers provide oversight for three-year mariculture program in Egypt and Israel
3. United Water, in partnership with Stevens, wins Management Innovation Award
4. Experts from Stevens, Merck, publish joint paper, Biosynthetic Studies of Platensimycin
5. NSF awards Stevens team $1 million for research on smart, bacteria-repellent nanohydrogels
6. Stevens Health, Technology, and Society roundtable: Oct. 31
7. Stevens wins Excellence in Technology Education Award
8. Ancient DNA: reconstruction of the biological history of Aldaieta necropolis
9. Sea cliff erosion, hemp construction materials and more at UCSD Engineering Conference
10. The construction of heart modelling leads path to new therapies
11. Researchers take first steps towards spinal cord reconstruction following injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015 To bolster its efforts and commitment ... announced today the addition of two new team members. ... advisor and David Raviv will act as head ... Corp.,s commitment to providing the most secure solutions for the ... co-founded Layer 7 Technologies, a provider of security and management ...
(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... America Biomedical Sensors market is estimated at $0.65 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... French . , Chicken sold in supermarkets, restaurants ... urinary tract infections (UTI), McGill researcher Amee Manges has discovered. ... in collaboration with the Public Health Agency of Canada and ... E. coli ( Escherichia coli ) bacteria originating from ...
... the first evidence from human research that blueberries ... other so-called phytochemicals improve memory. They said the ... to determine whether blueberries really deserve their growing reputation ... appears in ACS, Journal of Agricultural and Food ...
... a jury could decide a man,s guilt through mind reading? ... And what constitutes ,intent, to commit murder? These are ... inaugural issue of WIREs Cognitive Science, the latest interdisciplinary project ... the first two years. In the article "Neurolaw," ...
Cached Biology News:Retail meat linked to urinary tract infections: Strong new evidence 2Mind reading, brain fingerprinting and the law 2
(Date:7/1/2015)... 1, 2015   Neuraltus Pharmaceuticals, Inc. , a ... groundbreaking drugs to treat neurodegenerative diseases such as ... Robert G. Miller , M.D., Director of the Forbes ... Pacific Medical Center in San Francisco, has been awarded ... million to help fund a Phase 2 clinical ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Apex Therapeutics ... BIO International Convention in Philadelphia, PA. , The presentation took place on ... outlined the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
(Date:6/30/2015)... ... June 30, 2015 , ... uBiome ... new insights on mechanics of fecal microbiota transplantation in C. difficile patients. , ... microbiome of patients undergoing fecal microbiota transplantation (FMT) as a treatment for Clostridium ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... AMSTERDAM, December 15, 2011 Amsterdam Molecular Therapeutics ... therapy, announced today that the Company has a negative equity ... of this negative equity position is in line with previous ... is exploring alternatives for additional financing. AMT announced ...
... discovery of a new way to tune and enhance thermal ... for a given material gives engineers a new tool ... and a number of other powered devices. The finding ... Li, associate professor of mechanical engineering at Vanderbilt University, and ...
... SHANGHAI, Dec. 14, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... leading China-based pharmaceutical and biotechnology research and development outsourcing ... Morgan,s 30th Annual Healthcare Conference, to be held in ... Michael Xin Hui, founder and Chief Executive Officer of ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Announces Negative Equity Position 2Amsterdam Molecular Therapeutics Announces Negative Equity Position 3New method for enhancing thermal conductivity could cool computer chips, lasers and other devices 2New method for enhancing thermal conductivity could cool computer chips, lasers and other devices 3
... The nature of proteomics demands the ... The superior performance of the AXIMA-CFRplus with ... than 5 ppm) provides increased confidence in ... blanking for enhanced sensitivity, automated sample target ...
... Axima range, the AXIMA-CFR provides a ... sensitivity and mass range, and offers ... reflectron time-of-flight analysis. The unique patented ... of seamless PSD, providing efficient and ...
Rat Lung Fibroblasts (RLF) (>500,000 cells)...
...
Biology Products: